Literature DB >> 19728019

Feasibility and eligibility of retreatment with rabbit anti-T lymphocyte globulin for aplastic anemia previously treated with horse anti-thymocyte globulin.

Katsuhiro Miura1, Yoshihiro Hatta2, Sumiko Kobayashi2, Yoshinori Iriyama2, Kazuhiro Takei2, Jin Takeuchi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19728019     DOI： 10.1007/s12185-009-0417-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  10 in total

Review 1.  What is the definition of cure for aplastic anemia?

Authors:  B M Camitta
Journal:  Acta Haematol       Date:  2000       Impact factor: 2.195

2.  [Immunosuppressive therapy for adult aplastic anemia in a single institution study].

Authors:  Seiko Iki; Kensuke Usuki; Kimiko Iijima; Akio Urabe
Journal:  Rinsho Ketsueki       Date:  2005-04

3.  Treatment of aplastic anemia with an investigational antilymphocyte serum prepared in rabbits.

Authors:  R S Stein; R T Means; S B Krantz; J M Flexner; J P Greer
Journal:  Am J Med Sci       Date:  1994-12       Impact factor: 2.378

4.  Repeated treatment with horse antilymphocyte globulin for severe aplastic anaemia.

Authors:  A Tichelli; J Passweg; C Nissen; M Bargetzi; T Hoffmann; A Wodnar-Filipowicz; E Signer; B Speck; A Gratwohl
Journal:  Br J Haematol       Date:  1998-02       Impact factor: 6.998

5.  Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality.

Authors:  B M Camitta; E D Thomas; D G Nathan; G Santos; E C Gordon-Smith; R P Gale; J M Rappeport; R Storb
Journal:  Blood       Date:  1976-07       Impact factor: 22.113

6.  Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO)

Authors:  E Di Bona; F Rodeghiero; B Bruno; A Gabbas; P Foa; A Locasciulli; C Rosanelli; L Camba; P Saracco; A Lippi; A P Iori; F Porta; G De Rossi; B Comotti; P Iacopino; C Dufour; A Bacigalupo; V De Rossi
Journal:  Br J Haematol       Date:  1999-11       Impact factor: 6.998

7.  Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia.

Authors:  Phillip Scheinberg; Olga Nunez; Neal S Young
Journal:  Br J Haematol       Date:  2006-06       Impact factor: 6.998

8.  Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia.

Authors:  S J Rosenfeld; J Kimball; D Vining; N S Young
Journal:  Blood       Date:  1995-06-01       Impact factor: 22.113

9.  Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party.

Authors:  H Schrezenmeier; P Marin; A Raghavachar; S McCann; J Hows; E Gluckman; C Nissen; E T van't Veer-Korthof; P Ljungman; W Hinterberger
Journal:  Br J Haematol       Date:  1993-10       Impact factor: 6.998

10.  Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan.

Authors:  Masanao Teramura; Akiro Kimura; Satsuki Iwase; Yuji Yonemura; Shinji Nakao; Akio Urabe; Mitsuhiro Omine; Hideaki Mizoguchi
Journal:  Blood       Date:  2007-05-25       Impact factor: 22.113
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.